However, the preparation was either inadvertently or intentionally altered by an attendant to include five measures of active ingredient instead of the prescribed two.
The usual bowel preparation was either polyethylene glycol or sodium phosphate solution.
The dry-cow preparations used were either Curaclox DC (Cloxacillin 600 mg, Ampicillin 300 mg) from Norbrook (ARK-AH) P.O.
Preparations were observed either with a Philips CM12 electron microscope operating at 80 kV (FEI, Eindhoven, The Netherlands) or with a Jeol 1400 (Tokyo, Japan) mounted with CCD cameras (Morada, Olympus SIS, Germany).
In most of the studies, the inhibitory activity of tea could be demonstrated when tea preparations were given either during or after the carcinogen treatment period.
Negative control preparations were obtained either by incubating tissue sections with diluted primary antibody that had been preabsorbed with 10 mM of the respective peptide for 24 h at 4 °C, with preabsorption of the anti-PSA-NCAM antibody with 5 mg of colominic acid (alfa-2-8-linked sialic polymer colominic acid), or by omitting the primary antibody.
Two different preparations were used, either crude muscle extracts, used for the 6-week time point (10 mmol/L Tris-HCl, 1% Triton X-100, 0.5 μL/ml phenylmethanesulfonylfluoride [Roche], and protease inhibitor cocktail [Roche]) or the total membrane fraction isolated using a plasma membrane protein extraction kit (BioVision, Mountain View, CA), used for the 10-week and 6-month time points.
In contrast, in adenocarcinoma-bearing preparations, F rolling) and D adhering) were either unchanged (in the tumour centre) or reduced (in tumour periphery and the normal tissue surrounding the tumour) by radiation.
In contrast to the setting in our study the preparation with these multimedia presentations were either passive or an additional face-to-face session was required.
Prior to preparation of cell lysates, cells were either stimulated with DPBA (3 mmol/L) or with FCS (10%) for five minutes, or left unstimulated.
